DMK Pharmaceuticals Corporation
DMKPQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$1010
P/E Ratio—
52W High$0.001
52W Low$0.00001
DMK Pharmaceuticals Corporation (DMKPQ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DMKPQ · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 14, 2023EPS Actual
-$0.20
Revenue
$0.00B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 14, 2023
After Market Close
DMKPQ reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Jun 28, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Dec 26, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Sep 27, 2024 | -$0.21 | — | — | — | $0.00B | — |
| ◌ Q2 FY2024 | Jun 28, 2024 | -$0.51 | — | — | — | $0.00B | — |
| ◌ Q1 FY2024 | Jan 25, 2024 | -$0.42 | — | — | — | — | — |
| — Q4 FY2023 | Nov 14, 2023 | — | -$0.20 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$3.34 | — | $0.00B | — | — |
Q2 FY2025
Jun 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 26, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 27, 2024
EPS Actual
—
EPS Est.
-$0.21
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 28, 2024
EPS Actual
—
EPS Est.
-$0.51
EPS Surpr.
—
Revenue
—
Q1 FY2024
Jan 25, 2024
EPS Actual
—
EPS Est.
-$0.42
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 14, 2023
EPS Actual
-$0.20
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$3.34
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q3 FY2024 | $-0.20 | $-0.20 | $-0.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Nov 14, 2023 | — | $0.05 | $0.05 | -1.90% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.24 | $0.24 | +0.84% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.85 | $0.85 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -10.9% | $1.20 | $1.20 | +0.00% |
| ▲ Q3 FY2022 | Sep 29, 2022 | +2.2% | $1.62 | $1.62 | +0.00% |
| — Q2 FY2022 | Jun 29, 2022 | — | $3.31 | $3.31 | +0.00% |
Q4 FY2023-1.90%
Report Date
Nov 14, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q2 FY2023+0.84%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.85
Price After
$0.85
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-10.9%
Price Before
$1.20
Price After
$1.20
Q3 FY2022+0.00%
Report Date
Sep 29, 2022
EPS Beat/Miss
+2.2%
Price Before
$1.62
Price After
$1.62
Q2 FY2022+0.00%
Report Date
Jun 29, 2022
EPS Beat/Miss
—
Price Before
$3.31
Price After
$3.31
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate1 / 6 quarters
Largest Move-1.90% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DMKPQ ends December
DMK Pharmaceuticals Corporation (DMKPQ) most recently reported earnings on November 14, 2023 for Q4 FY2023, posting EPS of $-0.20 (in line with the analyst consensus of —). The next DMKPQ earnings date is expected around September 1, 2026.
Each quarter, investors track DMKPQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DMKPQ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DMKPQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DMKPQ earnings · 4 questionsDMK Pharmaceuticals Corporation's next earnings report is expected around September 1, 2026. DMKPQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DMKPQ historically reports after market close (AMC).
DMKPQ earnings datewhen is DMKPQ earningsDMKPQ next earnings datewhen does DMKPQ report earningsDMKPQ earnings calendar
▸ Source: FMP · DMK Pharmaceuticals Corporation SEC filings · US GAAP · DMK Pharmaceuticals Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026